Unconfigured Ad
Collapse
X
-
It's currently capped at 31, though I could make an unlimited-kmer-length version in a few hours. That would probably be worth doing, if I get some free time.
Leave a comment:
-
-
Introducing KmerCompressor, a tool for set operations on kmers
I'd like to introduce a new BBTool, KmerCompressor. This will take a dataset and reduce it to its set of constituent kmers, and print an optimally-condensed representation of them in fasta format, in which each kmer occurs exactly once. This is similar to an assembler, but it has additional capabilities regarding kmer count cutoffs that allow it to be used to perform arbitrary set operations on kmers, which allows advanced filtering of raw reads to capture specific features such as ribosomes, mitochondria, and chloroplasts, or filter by taxonomy.
The basic usage is like this:
kcompress.sh in=reads.fq out=set.fa
To get just the 31-mers that appear between 100 and 150 times in a dataset:
kcompress.sh in=reads.fq out=set.fa min=100 max=150 k=31
To use it for a set union (all the kmers in either of two files):
kcompress.sh in=ecoli.fa,salmonella.fa out=union.fa
With those basic operations, it is now possible to do various set operations. For example:
kcompress.sh in=fungal_genome.fa out=set_g.fa
kcompress.sh in=fungal_mitochondria.fa out=set_m.fa
Each of those sets has each kmer represented exactly once. Therefore, you can perform an intersection like this:
kcompress.sh in=set_g.fa,set_m.fa out=intersection.fa min=2
Or a subtraction like this:
kcompress.sh in=set_m.fa,intersection.fa out=m_minus_g.fa max=1
Then m_minus_g.fa contains all the kmers that are specific only to mitochondria in that organism, and could be used for filtering reads in an iterative assembly process.
I've been recently using it to create a set of ribosomal kmers for rapid metatranscriptome rRNA filtering using BBDuk, by reducing a very large ribosomal (16S/18S) database to just the set of kmers that occur often (and are thus both correct and conserved). This is useful for avoiding false positives, and reducing load time and memory usage compared to working with the entire database. For example:
dedupe.sh in=multiple_ribo_databases.fa.gz out=nodupes.fa.gz
kcompress.sh in=nodupes.fa.gz out=compressed.fa.gz k=31 min=5
...will result in a much smaller file, with similar (tunable) sensitivity and better specificity compared to the original. Subsequently, I run:
bbduk.sh in=metatranscriptome.fq.gz outu=nonribo.fq.gz outm=ribo.fq.gz ref=compressed.fa.gz k=31
...to separate the reads.
P.S. A link to a file I created with KmerCompressor: ribokmers.fa.gz
This 9MB file contains commonly-occurring ribosomal kmers from Silva. Used in conjunction with BBDuk, like this:
bbduk.sh in=reads.fq outm=ribo.fq outu=nonribo.fq k=31 ref=ribokmers.fa.gz
...it has a roughly 99.94% sensitivity against synthetic 1x150bp from the full Silva database (180MB compressed), a 99.98% sensitivity with hdist=1, and 99.994% sensitivity at k=25 hdist=1.Last edited by Brian Bushnell; 10-06-2015, 04:49 PM.
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 12:17 PM
|
0 responses
9 views
0 reactions
|
Last Post
by SEQadmin2
Today, 12:17 PM
|
||
|
Started by SEQadmin2, Yesterday, 11:41 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:41 AM
|
||
|
Started by SEQadmin2, 07-20-2026, 11:10 AM
|
0 responses
23 views
0 reactions
|
Last Post
by SEQadmin2
07-20-2026, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
Leave a comment: